|Year : 2020 | Volume
| Issue : 2 | Page : 104-108
Am I going blind?; Answers for clinical quiz
Ammar Hamad Al-Farsi1, Sana Al-Zuhaibi2, Anuradha Ganesh2
1 Department of Ophthalmology, Rustaq Hospital, Oman
2 Sultan Qaboos University Hospital, Oman
|Date of Submission||12-May-2019|
|Date of Decision||18-May-2019|
|Date of Acceptance||28-Oct-2019|
|Date of Web Publication||28-May-2020|
Department of Ophthalmology, Sultan Qaboos University Hospital, Seeb
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Al-Farsi AH, Al-Zuhaibi S, Ganesh A. Am I going blind?; Answers for clinical quiz. Oman J Ophthalmol 2020;13:104-8
An 18-year-old male presented with a history of gradual, painless, progressive deterioration of vision in both eyes (OU) noticed few months back. There were no other ocular complaints.
There was no significant medical history.
Family history was unremarkable.
His best-corrected visual acuity was 20/40 (−1.00–0.75 × 110) OD and 20/50 (0.50–0.25 × 51) OS.
Anterior segment examination was unremarkable OU. Dilated fundus examination revealed similar findings OU [Figure 1]. Optical coherence tomography (OCT) also showed abnormalities [Figure 2]. Electroretinogram (ERG) was done [Figure 3].
| Questions|| |
- What are the abnormal findings in [Figure 1], [Figure 2], [Figure 3]?
- What is the differential diagnosis?
- What is the most likely diagnosis from the available information and pictures?
- What is the treatment one may offer to this patient?
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
[Figure 1], [Figure 2], [Figure 3]